0001555667-15-000052.txt : 20150917
0001555667-15-000052.hdr.sgml : 20150917
20150917174341
ACCESSION NUMBER: 0001555667-15-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150915
FILED AS OF DATE: 20150917
DATE AS OF CHANGE: 20150917
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLAZYME INC
CENTRAL INDEX KEY: 0001311230
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 331077078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 GATEWAY BLVD.
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-780-4777
MAIL ADDRESS:
STREET 1: 225 GATEWAY BLVD.
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Licari Peter
CENTRAL INDEX KEY: 0001353937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35189
FILM NUMBER: 151113508
MAIL ADDRESS:
STREET 1: 225 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-09-15
0001311230
SOLAZYME INC
SZYM
0001353937
Licari Peter
SOLAZYME, INC.
225 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Technology Officer
Common Stock
2015-09-15
4
S
0
1562
3.0818
D
173967
D
Common Stock
2015-09-17
4
S
0
1562
3.1458
D
172405
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was designed to cover tax withholding obligations in connection with the concurrent vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.04 to $3.10, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.17, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Rob Maynes, as attorney-in-fact
2015-09-17